Epigenetic Therapies And Technologies: World Market Prospects 2013-2023
Ordering now lets you discover commercial prospects to 2023 for epigenetics
Visiongain's study is for everyone needing forward-looking analysis of pharmaceutical and diagnostic biotechnology. You find data, trends and predictions. Please ask for our report now.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6Table of Contents 1. Executive Summary 1.1 Epigenetic Therapies and Technologies: World Market Review1.2 Report Contents1.3 Research and Analysis Methods 2. An Introduction to Epigenetics 2.1 How is Epigenetics Defined? 2.1.1 Epigenetic Mechanisms 2.1.2 A Brief History of Epigenetic Research 2.2 The Links between Epigenetics and Disease 2.2.1 The Role of Lifestyle in Epigenetics 2.2.2 Epigenetics and Cancer 2.2.3 Epigenetics in Inherited Disorders 2.2.4 Epigenetics in Neurological Diseases 2.3 Epigenetics for Disease Diagnosis 2.3.1 Diagnosing for Breast Cancer 2.3.2 Colorectal Cancer: The Importance of Early Diagnosis 2.3.3 Diagnostics for Lung Cancer: Difficulty in Accessing Samples 2.3.4 Diagnostics for Prostate Cancer 2.4 The Use of Epigenetics in Treating Disease 2.4.1 DNA Methyltransferase (DNMT) Inhibitors 188.8.131.52 Myelodysplastic Syndromes (MDS) 2.4.2 Histone Deacetylase (HDAC) Inhibitors 184.108.40.206 Cutaneous T Cell Lymphoma (CTCL) 220.127.116.11 Peripheral T Cell Lymphoma (PTCL) 2.5 Drug Discovery and Development Tools Using Epigenetics 2.5.1 Bisulphite Screening for DNA Methylation 2.5.2 Chromatin Immunoprecipitation (ChIP) for Histone Modification 3. The Epigenetic Therapies and Technologies Market 2013-2023 3.1 The Epigenetic Therapies and Technologies Market 2011-20123.1.1 Leading Sectors of the Market 2011-20123.2 The Epigenetic Therapies and Technologies Market 2013-20233.2.1 The Epigenetic Therapies and Technologies Market: Overall Revenue Forecast 2013-20233.2.2 What Will Drive Revenue Growth for Epigenetic Therapies and Technologies?3.2.3 Rising Importance for Diagnostics Revenue 2013-20233.3 Epigenetic Therapies Submarket 2013-20233.3.1 Epigenetic Therapies Submarket: Revenue Forecast 2013-20233.3.2 Factors Influencing Epigenetic Therapy Uptake and Revenues 2013-20233.4 Epigenetic Technologies Submarket 2013-20233.4.1 Epigenetic Technologies Submarket: Revenue Forecast 2013-20233.4.2 Epigenetic Technologies Submarket: Drivers and Restraints 2013-20233.5 Epigenetic Diagnostics Submarket 2013-20233.5.1 Epigenetic Diagnostics Submarket: Revenue Forecast 2013-20233.5.2 New Product Launches to Drive Growth 2013-2023
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV